• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

针对环子孢子蛋白的人源抗体的细胞毒性被 3D 基质放大,并与保护作用相关。

Cytotoxicity of human antibodies targeting the circumsporozoite protein is amplified by 3D substrate and correlates with protection.

机构信息

Institut Pasteur, Université Paris Cité, Malaria Infection and Immunity, BioSPC, F-75015, Paris, France.

Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.

出版信息

Cell Rep. 2023 Jul 25;42(7):112681. doi: 10.1016/j.celrep.2023.112681. Epub 2023 Jun 28.

DOI:10.1016/j.celrep.2023.112681
PMID:37389992
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10468621/
Abstract

Human monoclonal antibodies (hmAbs) targeting the Plasmodium falciparum circumsporozoite protein (PfCSP) on the sporozoite surface are a promising tool for preventing malaria infection. However, their mechanisms of protection remain unclear. Here, using 13 distinctive PfCSP hmAbs, we provide a comprehensive view of how PfCSP hmAbs neutralize sporozoites in host tissues. Sporozoites are most vulnerable to hmAb-mediated neutralization in the skin. However, rare but potent hmAbs additionally neutralize sporozoites in the blood and liver. Efficient protection in tissues mainly associates with high-affinity and high-cytotoxicity hmAbs inducing rapid parasite loss-of-fitness in the absence of complement and host cells in vitro. A 3D-substrate assay greatly enhances hmAb cytotoxicity and mimics the skin-dependent protection, indicating that the physical stress imposed on motile sporozoites by the skin is crucial for unfolding the protective potential of hmAbs. This functional 3D cytotoxicity assay can thus be useful for downselecting potent anti-PfCSP hmAbs and vaccines.

摘要

人类针对疟原虫裂殖子表面环子孢子蛋白(PfCSP)的单克隆抗体(hmAbs)是预防疟疾感染的有前途的工具。然而,其保护机制仍不清楚。在这里,我们使用 13 种独特的 PfCSP hmAbs,全面了解 PfCSP hmAbs 如何中和宿主组织中的孢子。在皮肤中,孢子对 hmAb 介导的中和最敏感。然而,罕见但有效的 hmAbs 还可以中和血液和肝脏中的孢子。在组织中的有效保护主要与高亲和力和高细胞毒性 hmAbs 相关,这些 hmAbs 在没有补体和宿主细胞的情况下诱导寄生虫在体外迅速丧失适应性。3D 基质测定极大地增强了 hmAb 的细胞毒性,并模拟了皮肤依赖性保护,表明对运动的孢子施加的物理应激对于展开 hmAb 的保护潜力至关重要。因此,这种功能性 3D 细胞毒性测定可用于筛选有效的抗 PfCSP hmAbs 和疫苗。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/09d9/10468621/12fe247469a8/nihms-1920476-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/09d9/10468621/c38a3b42c709/nihms-1920476-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/09d9/10468621/901887d05136/nihms-1920476-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/09d9/10468621/1e87d3fa3e88/nihms-1920476-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/09d9/10468621/12fe247469a8/nihms-1920476-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/09d9/10468621/c38a3b42c709/nihms-1920476-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/09d9/10468621/901887d05136/nihms-1920476-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/09d9/10468621/1e87d3fa3e88/nihms-1920476-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/09d9/10468621/12fe247469a8/nihms-1920476-f0005.jpg

相似文献

1
Cytotoxicity of human antibodies targeting the circumsporozoite protein is amplified by 3D substrate and correlates with protection.针对环子孢子蛋白的人源抗体的细胞毒性被 3D 基质放大,并与保护作用相关。
Cell Rep. 2023 Jul 25;42(7):112681. doi: 10.1016/j.celrep.2023.112681. Epub 2023 Jun 28.
2
Mechanisms of protective immune responses induced by the Plasmodium falciparum circumsporozoite protein-based, self-assembling protein nanoparticle vaccine.由恶性疟原虫环子孢子蛋白为基础的自组装蛋白纳米颗粒疫苗诱导的保护性免疫应答的机制。
Malar J. 2013 Apr 22;12:136. doi: 10.1186/1475-2875-12-136.
3
Down-selecting circumsporozoite protein-based malaria vaccine: A comparison of malaria sporozoite challenge model.基于环子孢子蛋白的疟疾疫苗的选择:疟疾孢子虫挑战模型的比较。
Parasite Immunol. 2019 May;41(5):e12624. doi: 10.1111/pim.12624.
4
Protective effects of combining monoclonal antibodies and vaccines against the Plasmodium falciparum circumsporozoite protein.联合单克隆抗体和疫苗对疟原虫环子孢子蛋白的保护作用。
PLoS Pathog. 2021 Dec 6;17(12):e1010133. doi: 10.1371/journal.ppat.1010133. eCollection 2021 Dec.
5
Human antibodies activate complement against Plasmodium falciparum sporozoites, and are associated with protection against malaria in children.人体抗体可激活补体针对疟原虫孢子,与儿童疟疾保护有关。
BMC Med. 2018 Apr 30;16(1):61. doi: 10.1186/s12916-018-1054-2.
6
A Potent Anti-Malarial Human Monoclonal Antibody Targets Circumsporozoite Protein Minor Repeats and Neutralizes Sporozoites in the Liver.一种强效抗疟人源单克隆抗体靶向环子孢子蛋白小重复序列并中和肝脏中的孢子。
Immunity. 2020 Oct 13;53(4):733-744.e8. doi: 10.1016/j.immuni.2020.08.014. Epub 2020 Sep 17.
7
Liver-Directed AAV8 Booster Vaccine Expressing Antigen Following Adenovirus Vaccine Priming Elicits Sterile Protection in a Murine Model.腺病毒疫苗初免后靶向肝脏的 AAV8 增强型疫苗表达抗原可在小鼠模型中诱导无菌保护。
Front Immunol. 2021 Jun 23;12:612910. doi: 10.3389/fimmu.2021.612910. eCollection 2021.
8
Rare PfCSP C-terminal antibodies induced by live sporozoite vaccination are ineffective against malaria infection.经活孢子疫苗接种诱导的罕见 PfCSP C 端抗体对疟疾感染无效。
J Exp Med. 2018 Jan 2;215(1):63-75. doi: 10.1084/jem.20170869. Epub 2017 Nov 22.
9
Evolution of protective human antibodies against Plasmodium falciparum circumsporozoite protein repeat motifs.抗疟原虫环子孢子蛋白重复基序的保护性人抗体的进化。
Nat Med. 2020 Jul;26(7):1135-1145. doi: 10.1038/s41591-020-0881-9. Epub 2020 May 25.
10
Immunization of Malaria-Preexposed Volunteers With PfSPZ Vaccine Elicits Long-Lived IgM Invasion-Inhibitory and Complement-Fixing Antibodies.疟前免疫志愿者接种 PfSPZ 疫苗可诱导产生长寿命 IgM 入侵抑制和补体结合抗体。
J Infect Dis. 2018 Apr 23;217(10):1569-1578. doi: 10.1093/infdis/jiy080.

引用本文的文献

1
Analysis of Fc-dependent effector functions of anti-malaria circumsporozoite protein antibodies.抗疟疾环子孢子蛋白抗体的Fc依赖性效应功能分析
Microbiol Spectr. 2025 Jul 23:e0086325. doi: 10.1128/spectrum.00863-25.
2
Elicitation of liver-stage immunity by nanoparticle immunogens displaying P. falciparum CSP-derived antigens.展示恶性疟原虫环子孢子蛋白(CSP)衍生抗原的纳米颗粒免疫原引发肝期免疫。
NPJ Vaccines. 2025 May 5;10(1):87. doi: 10.1038/s41541-025-01140-x.
3
Late killing of sporozoites in the liver by an anti-circumsporozoite protein antibody.

本文引用的文献

1
Low-Dose Subcutaneous or Intravenous Monoclonal Antibody to Prevent Malaria.低剂量皮下或静脉注射单克隆抗体预防疟疾。
N Engl J Med. 2022 Aug 4;387(5):397-407. doi: 10.1056/NEJMoa2203067.
2
Expanding the Malaria Antibody Toolkit: Development and Characterisation of RH5, CyRPA, and CSP Recombinant Human Monoclonal Antibodies.扩大疟疾抗体工具包:RH5、CyRPA 和 CSP 重组人单克隆抗体的开发和特性。
Front Cell Infect Microbiol. 2022 Jun 16;12:901253. doi: 10.3389/fcimb.2022.901253. eCollection 2022.
3
Plasmodium sporozoite disintegration during skin passage limits malaria parasite transmission.
抗环子孢子蛋白抗体对肝脏中疟原虫子孢子的晚期杀伤作用。
Elife. 2025 Feb 14;14:RP105291. doi: 10.7554/eLife.105291.
4
Protective antibodies target cryptic epitope unmasked by cleavage of malaria sporozoite protein.保护性抗体靶向因疟原虫子孢子蛋白裂解而暴露的隐蔽表位。
Science. 2025 Jan 3;387(6729):eadr0510. doi: 10.1126/science.adr0510.
5
Monoclonal antibodies to the circumsporozoite proteins as an emerging tool for malaria prevention.针对环子孢子蛋白的单克隆抗体作为一种新兴的疟疾预防工具。
Nat Immunol. 2024 Sep;25(9):1530-1545. doi: 10.1038/s41590-024-01938-2. Epub 2024 Aug 28.
6
sporozoite shows distinct motility patterns in responses to three-dimensional environments.子孢子在对三维环境的反应中表现出明显的运动模式。
iScience. 2024 Jul 5;27(8):110463. doi: 10.1016/j.isci.2024.110463. eCollection 2024 Aug 16.
7
Killing of Sporozoites by Basic Amphipathic α-Helical Fusion Peptides.碱性两亲性α-螺旋融合肽对子孢子的杀伤作用。
Microorganisms. 2024 Feb 27;12(3):480. doi: 10.3390/microorganisms12030480.
8
Molecular determinants of cross-reactivity and potency by VH3-33 antibodies against the Plasmodium falciparum circumsporozoite protein.针对恶性疟原虫环子孢子蛋白的 VH3-33 抗体的交叉反应性和效力的分子决定因素。
Cell Rep. 2023 Nov 28;42(11):113330. doi: 10.1016/j.celrep.2023.113330. Epub 2023 Oct 28.
疟原虫孢子在皮肤传播过程中的解体限制了疟疾寄生虫的传播。
EMBO Rep. 2022 Jul 5;23(7):e54719. doi: 10.15252/embr.202254719. Epub 2022 Apr 11.
4
A Monoclonal Antibody for Malaria Prevention.疟疾预防用单克隆抗体。
N Engl J Med. 2021 Aug 26;385(9):803-814. doi: 10.1056/NEJMoa2034031. Epub 2021 Aug 11.
5
Structural and biophysical correlation of anti-NANP antibodies with in vivo protection against P. falciparum.抗 NANP 抗体的结构和生物物理相关性与体内抗疟原虫 falciparum 的保护作用。
Nat Commun. 2021 Feb 16;12(1):1063. doi: 10.1038/s41467-021-21221-4.
6
A Potent Anti-Malarial Human Monoclonal Antibody Targets Circumsporozoite Protein Minor Repeats and Neutralizes Sporozoites in the Liver.一种强效抗疟人源单克隆抗体靶向环子孢子蛋白小重复序列并中和肝脏中的孢子。
Immunity. 2020 Oct 13;53(4):733-744.e8. doi: 10.1016/j.immuni.2020.08.014. Epub 2020 Sep 17.
7
Evolution of protective human antibodies against Plasmodium falciparum circumsporozoite protein repeat motifs.抗疟原虫环子孢子蛋白重复基序的保护性人抗体的进化。
Nat Med. 2020 Jul;26(7):1135-1145. doi: 10.1038/s41591-020-0881-9. Epub 2020 May 25.
8
Optimization of an in vivo model to study immunity to Plasmodium falciparum pre-erythrocytic stages.优化体内模型以研究疟原虫红前期免疫。
Malar J. 2019 Dec 18;18(1):426. doi: 10.1186/s12936-019-3055-9.
9
Antibody-Mediated Protection against Sporozoites Begins at the Dermal Inoculation Site.抗体介导的对疟原虫子孢子的保护始于皮肤接种部位。
mBio. 2018 Nov 20;9(6):e02194-18. doi: 10.1128/mBio.02194-18.
10
Cytotoxic anti-circumsporozoite antibodies target malaria sporozoites in the host skin.细胞毒性抗环子孢子蛋白抗体靶向宿主皮肤中的疟原虫子孢子。
Nat Microbiol. 2018 Nov;3(11):1224-1233. doi: 10.1038/s41564-018-0254-z. Epub 2018 Oct 22.